Product category: Ultrasound diagnostic equipment, Anesthesiology equipment, anesthesiology systems
mprove patient satisfaction
Save time and money
Reduce risk of complications and placement failures
Improve the safety, speed, and efficiency of epidural and spinal anesthesia. Because Accuro automatically identifies epidural location with success rates exceeding 94%*, Accuro gives you confidence when performing epidurals or spinals, even in the most challenging patients.
Value of AccuroAccuros automated 3D spinal navigation technology is clinically proven to increase first-attempt success rates, reduce needle passes, reduce placement times, and significantly increase patient satisfaction with pain control. Collectively, these benefits significantly reduce the cost of care. RIVANNA can provide a customized analysis of how the Accuro adds value to any healthcare system – small or large. To request a detailed and customized value analysis, please contact us on our contact page.
ABOUT RIVANNA Based in Charlottesville, Virginia, RIVANNA is a privately held medical technology company that is commercializing its initial product, Accuro, an epidural guidance device designed to improve the success of epidural and spinal anesthesia.
This proprietary and versatile imaging device is FDA 510(k)-cleared for spinal anesthesia guidance and a variety of additional imaging applications, such as diagnostic imaging of musculoskeletal and abdominal anatomies.
RIVANNA was founded by Will Mauldin, Ph.D., and Kevin Owen, Ph.D., inventors of the companys proprietary Accuro platform, while they were Ph.D. students at the University of Virginia. Early development of the technology was made based upon collaborations between the prestigious UVa School of Medicine and Department of Biomedical Engineering. Development was funded in large part through the Wallace H. Coulter translational research partnership.